SARS CoV 2 Antigen Test Kit (Fluorescence Immunoassay)

Novel Coronavirus ((SARS-CoV-2) Antigen in the population Oropharyngeal swabs or Nasopharyngeal swab samples are qualitatively detected by the colloidal gold method. After mixing the population Oropharyngeal swabs or Nasopharyngeal swabs, the new Coronavirus (SARS-CoV-2) Antigen in the population will be tested SARS-CoV-2 Antigen-SARS-CoV-2 is combined with the novel coronavirus (SARS-CoV-2) antibody labeled with colloidal gold on the binding pad to form the antibody-colloidal gold complex. Due to chromatography, SARS-CoV-2 Antigen- The SARS-CoV-2 antibody-colloidal gold complex diffuses across the nitrocellulose membrane. Within the detection line area, the SARS-CoV-2 Antigen-antibody complex binds to the antibody contained within the detection line area. Antibody 2 diffuses into the quality control line (C) region and is captured by sheep anti-mouse IgG to form red bands.

  • Features
  • Image & Video
  • Document
  • This kit is a qualitative test and is used for in vitro ancillary diagnosis only.
  • The limit of the antigen detection reagent method and the minimum limit of detection (sensitivity analysis) are generally lower than that of the nucleic acid reagent. Therefore, the researcher should pay attention to possible false negative situations. The investigator should also look at patients' symptoms. Further testing, including nucleic acid tests for suspected negative results, is recommended to aid decision making.
  • Improper sampling, handling, processing and low virus content in samples can cause false negatives.
  • Test results for this reagent are for clinical reference only and should not be used as the sole basis for clinical diagnosis and treatment. The definitive diagnosis of the disease should be based on a comprehensive assessment of all clinical conditions and laboratory results once made.

fluorecare COVID-19 Antibody&Antigen Rapid Test Kit Product Brochure